scispace - formally typeset
S

Seiji Kondo

Researcher at University of Texas MD Anderson Cancer Center

Publications -  96
Citations -  12134

Seiji Kondo is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Apoptosis & Glioma. The author has an hindex of 53, co-authored 95 publications receiving 11532 citations. Previous affiliations of Seiji Kondo include Mount Sinai Hospital & Baylor College of Medicine.

Papers
More filters
Journal ArticleDOI

The role of autophagy in cancer development and response to therapy

TL;DR: It is still unclear whether autophagy suppresses tumorigenesis or provides cancer cells with a rescue mechanism under unfavourable conditions, and how can the autophagic process be manipulated to improve anticancer therapeutics.
Journal ArticleDOI

The Energy Sensing LKB1-AMPK Pathway Regulates p27kip1 Phosphorylation Mediating the Decision to Enter Autophagy or Apoptosis

TL;DR: LKB1–AMPK pathway-dependent phosphorylation of p27 at Thr 198 stabilizes p27 and permits cells to survive growth factor withdrawal and metabolic stress through autophagy, which may contribute to tumour-cell survival under conditions of growth factor deprivation, disrupted nutrient and energy metabolism, or during stress of chemotherapy.
Journal Article

Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.

TL;DR: The findings suggest that As(2)O(3) at a clinically safe concentration may be an effective chemotherapeutic agent for malignant gliomas.
Journal ArticleDOI

Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B Inhibitors

TL;DR: The results indicate that rapamycin exerts its antitumor effect on malignant glioma cells by inducing autophagy and suggest that in malignantgliomas cells a disruption of the PI3K/Akt signaling pathway could greatly enhance the effectiveness of mTOR inhibitors.